Evidence map›Paper›PMID 41853220›Full record

ReviewESMO real world data and digital oncology2026

Prediction models of adverse outcomes following surgery and radiotherapy for breast cancer: a systematic review.

H Asfour, B Wang, H Zhou, A Al Janapy, N G Patel, R P Symonds, C J Talbot, T Rattay

Abstract readReview
In one paragraph

Review in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

H AsfourDepartment of Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK.
B WangSchool of Mathematics and Computer Science, University of Leicester, Leicester, UK.
H ZhouSchool of Mathematics and Computer Science, University of Leicester, Leicester, UK.
A Al JanapyLeicester Cancer Research Centre, Department of Genetics, Genomics & Cancer Sciences, University of Leicester, Leicester, UK.
N G PatelDepartment of Plastic Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK.
R P SymondsLeicester Cancer Research Centre, Department of Genetics, Genomics & Cancer Sciences, University of Leicester, Leicester, UK.
C J TalbotLeicester Cancer Research Centre, Department of Genetics, Genomics & Cancer Sciences, University of Leicester, Leicester, UK.
T RattayDepartment of Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast surgery and radiotherapy are the most common treatment modalities for breast cancer, although both may have side-effects that can affect quality of life. Being able to identify patients at risk of adverse outcomes would enable optimisation of individualised treatment plans to improve the experience of breast cancer survivors. A systematic review of prediction models for adverse outcomes following surgery and radiotherapy for breast cancer was conducted. PubMed, Medline, Scopus, Web of Science, and CINAHL databases were searched using relevant key words and Medical Subject Heading terms. The search yielded 5376 articles, of which 33 articles were included. Data were extracted on study design, sources of training and test/validation data, predictors, outcomes, model performance, and validation. Several prediction models for adverse outcomes following breast surgery with or without radiotherapy have been developed. For short-term side-effects, these include the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator, the Breast Reconstruction Risk Assessment score, and the Breast Cancer Surgery Risk Calculator. Despite the relatively large training datasets used in the development of prediction models, they suffer from a relative lack of external validation. There is as yet no externally validated prediction model for long-term adverse outcomes, although machine learning and multiscale finite element models show promise. Overall, while significant advancements have been made in developing these prediction models, the majority are not yet ready for widespread clinical implementation. This systematic review also highlights a lack of prediction models for long-term side-effects and more complex outcomes, suggesting areas for future research.

Indexed as

adverse outcomesbreast cancerbreast reconstructionbreast surgeryprediction modelradiotherapy

Identifiers

PMID41853220
PMCPMC12993883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.